Company
Capacity Bio
Targeting mitochondrial biology to power therapeutic breakthroughs
Also known as Capacity Bio Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Capacity Bio Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Capacity Bio, Inc., a mitochondria-focused biotechnology company developing novel mitophagy modulators
Funding snapshot
- Total raised
- $35MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Undisclosed, $35M2023-03-31
Funding rounds
- Round, 2023
- $35M2023-03-31, Company stated
- Round, 2022
- $19.2M2022-12-21, SEC form D sold, 13 investors
Loading relationship preview